Tonghua Dongbao Pharmaceutical Co., Ltd. and Ypsomed are announcing a new insulin pen system for the Chinese market. The Sulin Pen is based on the YpsoPen technology platform, an inexpensive reusable pen. The value Sulin Pen perfectly complements the existing premium Gansulin Pen, which is based on Ypsomed’s ServoPen platform.
